Verition Fund Management »

Lexeo Therapeutics shares owned by Verition Fund Management

Quarter-by-quarter ownership of Lexeo Therapeutics (LXEO) shares owned by Verition Fund Management from 13F filings

Historical chart of Verition Fund Management investment in Lexeo Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Lexeo Therapeutics held by Verition Fund Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Lexeo Therapeutics by Verition Fund Management

Quarter filed Position value Share count Share price at filing
2024-12-31 $4.7M 710k 6.58
2024-09-30 $7.0M 777k 9.04
2024-06-30 $6.8M 421k 16.04
2024-03-31 $954k 61k 15.68

More positions owned by Verition Fund Management

Ishares Tr Core S&p500 Etf (IVV)
NVIDIA Corporation Put Option (NVDA)
Microsoft Corporation (MSFT)
Spdr S&p 500 Etf Tr Tr Unit (SPY)
Amazon (AMZN)
Taiwan Semiconductor Mfg Sponsored Ads (TSM)
Apple Call Option (AAPL)
Advanced Micro Devices (AMD)
Arm Holdings Sponsored Ads Put Option (ARM)
Procter & Gamble Company Call Option (PG)
Popular Com New (BPOP)
Paypal Holdings (PYPL)
Ishares Tr 20 Yr Tr Bd Etf (TLT)
Entergy Corporation (ETR)
Old National Ban (ONB)

View all positions for Verition Fund Management

Top funds holding Lexeo Therapeutics

Henderson Group
Citadel Advisors
Adage Capital Partners GP
D1 Capital Partners
BlackRock
Eventide Asset Management
Omega Fund Management
Blackstone Group
Novo A/S
Vanguard Group
Frazier Life Sciences Management
Woodline Partners
Vestal Point Capital
Point72 Asset Management
Verition Fund Management

View all funds holding Lexeo Therapeutics